Related Experiment Video
Updated: May 21, 2026

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts
Published on: October 9, 2016
Protective Function of STAT3 in CVB3-Induced Myocarditis
Diana Lindner1, Moritz Hilbrandt, Katharina Marggraf
1Department of Cardiology and Pneumology, Charité-Universitäts-Medizin Berlin, Campus Benjamin Franklin, 12200 Berlin, Germany.
Insights
Signal transducer and activator of transcription 3 (STAT3) protects the heart during viral myocarditis. STAT3 deficiency in cardiomyocytes increases cardiac fibrosis and impairs function after Coxsackievirus B3 infection.
Area of Science:
- Cardiovascular Research
- Immunology
- Virology
Background:
- Signal transducer and activator of transcription 3 (STAT3) is a key mediator in inflammatory processes.
- Viral myocarditis can progress to dilated cardiomyopathy.
- The specific role of STAT3 in cardiomyocyte-mediated inflammation and fibrosis is not fully understood.
Purpose of the Study:
- To investigate the role of STAT3 in viral myocarditis induced by Coxsackievirus B3 (CVB3).
- To determine if STAT3 deficiency in cardiomyocytes contributes to the development of dilated cardiomyopathy.
- To elucidate the protective mechanisms of STAT3 signaling in the heart during viral infection.
Main Methods:
- Utilized STAT3-deficient mice with cardiomyocyte-restricted knockout (STAT3 KO).
- Induced viral myocarditis using Coxsackievirus B3 (CVB3) infection.
- Assessed viral clearance, inflammation, cardiac function, collagen I expression, and matrix degradation at 4 weeks post-infection.
Main Results:
- STAT3 KO mice exhibited severe inflammation during the acute phase of CVB3 infection.
- While virus clearance and inflammation were attenuated by 4 weeks in both groups, STAT3 KO mice showed significantly decreased cardiac function.
- Increased collagen I expression and reduced matrix degradation were observed in STAT3 KO mice, indicating enhanced fibrosis.
Conclusions:
- STAT3 signaling in cardiomyocytes plays a protective role against CVB3-induced myocarditis.
- Cardiomyocyte-specific STAT3 deficiency leads to increased cardiac fibrosis, suggesting a protective function through paracrine effects.
- STAT3 signaling is crucial for maintaining cardiac function and preventing excessive fibrosis during viral myocarditis.
Abstract:
The transcription factor signal transducer and activator of transcription 3 (STAT3) is an important mediator of the inflammatory process. We investigated the role of STAT3 in viral myocarditis and its possible role in the development to dilated cardiomyopathy. We used STAT3-deficent mice with a cardiomyocyte-restricted knockout and induced a viral myocarditis using Coxsackievirus B3 (CVB3) which induced a severe inflammation during the acute phase of the viral myocarditis. A complete virus clearance and an attenuated inflammation were examined in both groups WT and STAT3 KO mice 4 weeks after infection, but the cardiac function in STAT3 KO mice was significantly decreased in contrast to the infected WT mice. Interestingly, an increased expression of collagen I was detected in STAT3 KO mice compared to WT mice 4 weeks after CVB3 infection. Furthermore, the matrix degradation was reduced in STAT3 KO mice which might be an explanation for the observed matrix deposition. Consequently, we here demonstrate the protective function of STAT3 in CVB3-induced myocarditis. Since the cardiomyocyte-restricted knockout leads to an increased fibrosis, it can be assumed that STAT3 signalling in cardiomyocytes protects the heart against increased fibrosis through paracrine effects.
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
The JAK-STAT Signaling Pathway
Cardiomyopathy III: Hypertrophic Cardiomyopathy
